Comparison of Insulin Mix25 Versus Mix50

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 403 participants.

Also called NCT01773473

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 403 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01773473
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China, Japan, South Korea, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01773473. Randomized; no masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2015-05-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Insulin Mix25 Versus Mix50
Acronym
CLASSIFY
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Insulin Lispro Mix25
Intervention (Drug)
Insulin Lispro Mix50
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01773473
Content hash
b754d10716a0183f7ac6e0c5422d2bca1db868072e315a37f69db11ba9fc0968